Kumasaka, Natsuhiko http://orcid.org/0000-0002-3557-0375
Rostom, Raghd
Huang, Ni
Polanski, Krzysztof http://orcid.org/0000-0002-2586-9576
Meyer, Kerstin B. http://orcid.org/0000-0001-5906-1498
Patel, Sharad
Boyd, Rachel
Gomez, Celine
Barnett, Sam N. http://orcid.org/0000-0002-8968-4319
Panousis, Nikolaos I.
Schwartzentruber, Jeremy
Ghoussaini, Maya http://orcid.org/0000-0002-2415-2143
Lyons, Paul A. http://orcid.org/0000-0001-7035-8997
Calero-Nieto, Fernando J. http://orcid.org/0000-0003-3358-8253
Göttgens, Berthold http://orcid.org/0000-0001-6302-5705
Barnes, Josephine L. http://orcid.org/0000-0001-9938-3176
Worlock, Kaylee B. http://orcid.org/0000-0002-5656-7634
Yoshida, Masahiro http://orcid.org/0000-0002-3521-5322
Nikolić, Marko Z. http://orcid.org/0000-0001-6304-6848
Stephenson, Emily
Reynolds, Gary http://orcid.org/0000-0002-8142-8708
Haniffa, Muzlifah http://orcid.org/0000-0002-3927-2084
Marioni, John C. http://orcid.org/0000-0001-9092-0852
Stegle, Oliver http://orcid.org/0000-0002-8818-7193
Hagai, Tzachi http://orcid.org/0000-0002-4575-6624
Teichmann, Sarah A. http://orcid.org/0000-0002-6294-6366
Funding for this research was provided by:
Wellcome Trust (WT206194, WT206194, WT206194, WT206194, WT206194, 206328/Z/17/Z, WT206194, WT206194)
Rosetrees Trust (M944, M944)
Action Medical Research (GN2911, GN2911)
Evelyn Trust (20/75)
RCUK | MRC | Medical Research Foundation (MR/S036113/1, MR/S036113/1)
Article History
Received: 28 August 2021
Accepted: 27 April 2023
First Online: 12 June 2023
Competing interests
: S.A.T. has received remunerations for consulting and Scientific Advisory Board work from TransitionBio, GlaxoSmithKline, Qiagen and Foresite Labs over the past 3 years and is an equity holder of TransitionBio. All other authors declare no competing interests.